7Baggers
 Anavex reports positive safety data for schizophrenia drug candidate By Investing.com  Investing.com Australia Fri, 03 Oct 2025 02:52:07 GMT
 Anavex Life Sciences (AVXL): Analyst Reaffirms "Buy" Rating | AV  GuruFocus Thu, 02 Oct 2025 15:07:05 GMT
 Anavex posts trial data for schizophrenia drug (AVXL:NASDAQ)  Seeking Alpha Thu, 02 Oct 2025 14:27:00 GMT
 Anavex (AVXL) Advances ANAVEX3-71 with New Once-Daily Tablet For  GuruFocus Thu, 02 Oct 2025 12:29:41 GMT
 anavex reports successful development of once-daily tablet for anavex3-71  Investing.com Australia Thu, 02 Oct 2025 12:25:14 GMT
 Anavex (AVXL) Achieves Key Milestone in Schizophrenia Drug Study  GuruFocus Thu, 02 Oct 2025 12:04:53 GMT
 Why Anavex Is Rising In Pre-market?  Nasdaq Thu, 02 Oct 2025 11:52:00 GMT
 Anavex Life Sciences Announces Publication of Oral  GlobeNewswire Tue, 30 Sep 2025 12:33:20 GMT
 anavex life sciences files $300m common stock offering  MSN Wed, 24 Sep 2025 08:32:23 GMT
 published on: 2025-09-22 05:58:42  newser.com Mon, 22 Sep 2025 10:58:42 GMT
 anavex stock rallies 30% on business updates  MSN Sun, 21 Sep 2025 13:04:35 GMT
 united states rett syndrome market driven by rising gene therapy  openPR.com Mon, 15 Sep 2025 16:23:53 GMT
 published on: 2025-09-16 05:38:20  خودرو بانک Mon, 15 Sep 2025 15:03:37 GMT
 anavex life sciences (nasdaq:avxl) trading up 9% - here's why  MarketBeat Sun, 14 Sep 2025 07:00:00 GMT
 anavex life sciences (nasdaq:avxl) trading up 9% - what's next?  MarketBeat Sat, 13 Sep 2025 07:00:00 GMT
 on blarcamesine for alzheimer disease, with christopher missling, phd  Psychiatric Times Fri, 12 Sep 2025 07:00:00 GMT
 breakeven on the horizon for anavex life sciences corp. (nasdaq:avxl)  富途牛牛 Wed, 10 Sep 2025 13:09:02 GMT
 avxl's buy rating and price target maintained by analyst jason k  GuruFocus Wed, 10 Sep 2025 12:33:23 GMT
 anavex life sciences out with new drug to fight effects of aging  Baystreet.ca Tue, 09 Sep 2025 14:00:00 GMT
 anavex (avxl) reports promising blarcamesine results for early a  GuruFocus Tue, 09 Sep 2025 12:32:12 GMT
 anavex announces latest findings for blarcamesine  TipRanks Tue, 09 Sep 2025 11:47:28 GMT
 anavex life sciences, oil companies, yum brands  TradingView Tue, 09 Sep 2025 07:00:00 GMT
 anavex life sciences climbs after alzheimer's drug trial data  TradingView Tue, 09 Sep 2025 07:00:00 GMT
 anavex life sciences, oil companies, yum! brands  TradingView Tue, 09 Sep 2025 07:00:00 GMT
 published on: 2025-09-03 23:07:21  Newser Thu, 04 Sep 2025 04:07:21 GMT
 published on: 2025-09-03 01:45:56  Newser Wed, 03 Sep 2025 06:45:56 GMT
 published on: 2025-09-02 01:15:53  khodrobank.com Mon, 01 Sep 2025 21:47:32 GMT

Anavex Life Sciences Corp
(NASDAQ:AVXL) 

AVXL stock logo

Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Pha...

Founded: 2004
Full Time Employees: 16
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends